Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Epizyme (EPZM) News Today

Epizyme logo
bluebird bio Inc BLUE
Epizyme, Inc. stock logo
Epizyme (NASDAQ:EPZM) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Epizyme in a research report on Monday. They issued a "hold" rating on the stock.
Epizyme: Q2 Earnings Insights - Benzinga
Epizyme: Q2 Earnings Snapshot
EPIZYME INVESTOR ALERT by the - GuruFocus.com
Epizyme, Inc. stock logo
Epizyme, Inc. (NASDAQ:EPZM) Given Average Recommendation of "Hold" by Brokerages
Epizyme, Inc. (NASDAQ:EPZM - Get Rating) has earned a consensus recommendation of "Hold" from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendatio
Epizyme, Inc. stock logo
Epizyme (NASDAQ:EPZM) Downgraded by Cowen to "Market Perform"
Cowen cut shares of Epizyme from an "outperform" rating to a "market perform" rating in a report on Monday.
Epizyme shares soar 60% on acquisition news
Get Epizyme News Delivered to You Automatically

Sign up to receive the latest news and ratings for EPZM and its competitors with MarketBeat's FREE daily newsletter.

Elon knows the truth, which is why they want him silenced (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

EPZM Media Mentions By Week

EPZM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EPZM
News Sentiment

0.22

0.44

Average
Medical
News Sentiment

EPZM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EPZM Articles
This Week

0

0

EPZM Articles
Average Week

Get Epizyme News Delivered to You Automatically

Sign up to receive the latest news and ratings for EPZM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:EPZM) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners